Published on 23/12/2025
What ICH-GCP Guidelines Say About Categorizing Clinical Trial Deviations
Overview of ICH-GCP Deviation Principles
The International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines serve as the global foundation for conducting clinical trials ethically and scientifically. While ICH-GCP does not provide a rigid definition of “major” and “minor” protocol deviations, it lays out clear expectations for documentation, assessment, and corrective action regarding all deviations from the protocol, SOPs, or regulations.
ICH E6(R2), the most current version of the guideline, emphasizes the role of sponsors and investigators in ensuring that deviations are appropriately tracked, evaluated, and handled based on their impact. Whether a deviation is categorized as major or minor should be based on a risk-based approach, aligning with subject safety and data integrity.
The ICH-GCP expectations are recognized by major regulatory agencies, including the FDA, EMA, PMDA, and CDSCO, and influence how deviations are viewed during inspections, audits, and submissions.
Key ICH-GCP Clauses Related to Deviations
ICH-GCP directly and indirectly addresses deviation handling in several clauses. The most relevant are:
- 4.5.2: The investigator should not implement any deviation from, or changes to, the protocol without prior review and documented approval/favorable opinion from the IRB/IEC and the sponsor.
- 4.5.3: The investigator
While these clauses don’t explicitly reference “major” or “minor” terminology, they provide the framework for sponsors and sites to establish classification procedures that meet regulatory expectations.
ICH-GCP Aligned Criteria for Deviation Categorization
Most sponsors create a deviation categorization matrix based on the risk to subject safety and data integrity, in line with ICH principles. This matrix typically includes:
| Category | Description | ICH-GCP Risk Alignment |
|---|---|---|
| Major | Deviations impacting subject safety, rights, or critical data (e.g., consent errors, eligibility breaches) | High – Must be documented, escalated, and followed with CAPA |
| Minor | Deviations with negligible risk (e.g., administrative delays, non-critical window misses) | Low – Still documented and reviewed |
ICH-GCP promotes a risk-based monitoring approach (RBM), meaning categorization must also account for systemic versus isolated events. For example, a single missed ECG may be minor, but 10 missed ECGs across multiple subjects may require reclassification as a major trend.
Documenting Deviation Categorization Per ICH-GCP
Under ICH-GCP, it is essential to document:
- ✅ A full description of the deviation (what, when, who, impact)
- ✅ Categorization rationale (why major or minor)
- ✅ Assessment of subject impact (safety, rights, well-being)
- ✅ Assessment of impact on data credibility
- ✅ Whether regulatory reporting was needed
- ✅ Whether a CAPA was triggered and executed
These elements help fulfill ICH’s requirements for traceable, verifiable documentation and prepare sites and sponsors for inspection readiness.
Role of Sponsor and Investigator in Deviation Classification
ICH-GCP allocates deviation responsibilities to both sponsors and investigators. According to ICH E6(R2):
- Investigators must avoid deviations unless necessary to prevent immediate hazard and document all events.
- Sponsors must evaluate, trend, and report significant non-compliance, ensure protocol adherence, and assess whether further investigation or CAPA is required.
Case example: In a global trial, a site implemented a local lab test in place of the central lab. The sponsor initially treated it as a minor deviation. However, after a trend review revealed 8 instances across 3 sites, the event was reclassified as major and required a CAPA. This escalation aligned with ICH-GCP’s requirement for quality management and continuous improvement.
ICH-GCP Expectations During Regulatory Inspections
Inspectors often assess whether a sponsor’s deviation management aligns with ICH-GCP. Common findings include:
- ❌ No rationale provided for deviation categorization
- ❌ Missing or vague deviation narratives
- ❌ No evidence of impact assessment or sponsor oversight
- ❌ Failure to reclassify recurring minor deviations as systemic
Best practices include training CRA teams on ICH expectations, maintaining deviation matrices as part of the TMF, and conducting periodic quality reviews of logs and narratives.
Alignment with ICH-GCP Through SOPs and Quality Systems
To align with ICH-GCP, sponsors and CROs must embed deviation classification procedures into:
- ✅ Standard Operating Procedures (SOPs)
- ✅ Site initiation visit (SIV) and protocol training materials
- ✅ Central monitoring plans and QTL tracking systems
- ✅ Inspection readiness plans
Deviation logs should be periodically trended using RBM tools to identify risk signals early. A Deviation Review Committee may be formed for high-risk trials to oversee classification consistency across sites.
Conclusion: Categorization Is Key to ICH-GCP Compliance
Though ICH-GCP doesn’t define deviation categories explicitly, it establishes the framework for how all deviations must be handled—risk-assessed, documented, escalated, and resolved. Proper deviation categorization is central to ICH’s principles of subject protection, data integrity, and quality assurance.
By embedding clear classification logic, training, and documentation practices into your clinical operations, you ensure not just ICH compliance—but also smoother inspections, fewer audit findings, and better clinical outcomes.